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nosis)) AND discordance[Title/Abstract]) AND lymphoma)) OR ((lymphoma[Title]) 
AND pathology[Title]). The pooled major discordance frequency was calculated 
using Neyeloff, Fuchs and Moreira’s Excel random effects model (2012). Weighted 
averages using a random-effects model are reported with 95% confidence intervals 
with continuity correction. Results: Eight (8) articles evaluating and differentiat-
ing minor and major second-opinion discordance in lymphoma diagnosis were 
included in this study. Major discordance is defined as diagnostic discrepancy 
between the preliminary or final diagnosis and second-opinion review that is 
determined by the study authors could have an impact on patient management. 
The proportion of discordance that was major ranged from 4.27% to 20.00%. The 
pooled proportion of major discordance was 9.10% (95% CI 5.86%-12.35%) in a 
pooled sample of 5,322 lymphoma patients. Only 1 study, a published abstract, 
analyzed the actual patient impact of discordant pathological results through 
chart review, determining 2.9% of patients were over-treated, under-treated, had 
significant change in treatment or incorrect treatment due to diagnostic error 
(Kukreti et al., 2006). ConClusions: Diverse methodologies led to considerably 
variable estimates; however, this meta-analysis revealed that an estimated 9.10% 
of lymphoma diagnoses could be incorrect to the point of impacting patient treat-
ment management.
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objeCtives: Currently various diagnostic pathways for incidentally detected pul-
monary nodules are used and it is not clear which diagnostic pathway should be 
used to potential lung cancer. An early diagnosis of a possible malignancy in the 
lung is important in order to increase the survival chance of the patient. In this study 
the regular used Fleischner Recommendations are compared with a software based 
volume doubling time(VDT) technique. Methods: A model of the two possible 
diagnostic pathways is developed and built in R. The used incidence rates of pulmo-
nary nodules and lung cancer are obtained from literature. The primary endpoint is 
the incidence rate of lung cancer after one year. Secondary endpoints are the test 
results of the diagnostic pathways. Ten thousand patiens were included in order to 
decrease bias and increase precision of the model. Results: Diagnosis with help 
of VDT led to a lower rate of false postives and false negatives, compared to the 
Fleischner Recommendations. Furthermore, € 188.394,66 was saved in the simula-
tion when VDT was used. The sensitivity of VDT could decrease with 7 percent in 
order to be as good as Fleischner Criteria, and was still cheaper. ConClusions: The 
replacement of the Fleischner Recommendation by software based VDT can lead 
to a decrease in false positives and false negatives. Since the total costs of VDT are 
lower than the costs of the Fleischner Recommendation also a reduction in health 
care costs is possible. However, since this was an early-stage research more direct 
evidence should be collected in the future.
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objeCtives: To understand and quantify the clinical and economic impact of an 
automated, on-demand diagnostic test versus current diagnostic tests, for hep-
arin-induced thrombocytopenia (HIT). Methods: A mixed methods study com-
bining a literature review with primary research. The literature review searched 
multiple databases to identify data on test performance, clinical and economic 
data. Semi-structured interviews (n= 4) provided insight into current practice and 
challenges faced, validated by a larger survey (n= 90). Two flow diagrams modelling 
a hypothetical cohort of 1000 patients were used to calculate the clinical and cost 
impact of automated, on-demand testing. Results: The automated, on-demand 
test had comparable or lower sensitivity, and a higher specificity than other avail-
able tests. Clinical data and survey findings indicate that the specificity of the most 
widely used antibody tests (ELISA) is suboptimal. The survey revealed that half of 
patients are speculatively switched off of heparin and onto replacement therapy 
based on clinical assessment alone, rather than based on clinical assessment and 
diagnostic test results as per guideline recommendations. Speculative treatment 
is driven by test turnaround time of > 24 hours for > 50% of respondents. The cost 
model indicated that the cost of replacement therapy whilst awaiting tests results 
of > 24 hours’ turnaround time was between $7215 and $31268. Automated, on-
demand antibody testing and switching patients off heparin based on test results 
reduced this cost to between $2737 and $13092. ConClusions: Automated, on-
demand HIT antibody testing could enable physicians to use timely diagnostic test 
results with better specificity than current tests to make treatment decisions. This 
could potentially enable earlier treatment of HIT to reduce complications such as 
extended hospitalisation and death, thus improving clinical outcomes and reduc-
ing costs. Also, earlier informed treatment decisions could yield pathway cost 
reductions through reducing the use of replacement therapies in non-confirmed 
and false positive cases.
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have comparable cycles for both strategies a three-year time horizon was used 
for cost comparison. Total screening costs were 26% lower for HPV genotyping 
and only 21% higher for treatment costs, resulting in total savings of 1.6 million 
over cytology. ConClusions: Compared to cytology, incorporation of cobas HPV 
genotyping test as primary screening for CxCa at IMSS represents during the 
first-cycle potential savings of 10% as an improvement in clinical benefits, such 
as reduction in the incidence and mortality due to CxCa.
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objeCtives: The fraction of exhaled nitric oxide (FeNO), a marker of eosinophilic 
inflammation, may be a useful diagnostic test in asthma. This systematic review 
aimed to identify and synthesise evidence relating to the diagnostic accuracy of 
FeNO for asthma. Methods: Systematic searches of nine key biomedical data-
bases and trial registers (including MEDLINE, EMBASE , the Cochrane library and 
clinicaltrials.gov) were carried out to November 2014. Records were considered by 
one reviewer and included if they: recruited patients presenting with the symp-
toms of asthma; used a single set of criteria (i.e. not case-control); measured 
FeNO in accordance with American Thoracic Society guidelines, 2005 (off-line 
measurements excluded); reported/allowed calculation of true positive, true nega-
tive, false positive and false negative patients as classified against any reference 
standard. Study quality was assessed using QUADAS II. Data was extracted by one 
reviewer using a standardised form and checked by a second. Meta-analysis was 
planned where clinical study heterogeneity allowed. Rule-in and Rule-out uses 
of FeNO were considered. Results: 4865 records were identified and 32 studies 
were included. 5 studies recruited children and/or adolescents, and 27 studies 
recruited mixed ages or adults. Studies were sub-grouped by study characteris-
tics. Heterogeneity precluded meta-analysis. Cut-off values for the best sum of 
sensitivity and specificity varied from 12ppb to 55ppb, being generally lower in 
children. Results varied, but the highest sum of sensitivity and specificity was 
reported for patients with chronic cough using a reference standard of airway 
reversibility testing (sensitivity 90% and specificity 85%). 100% sensitivity or 100% 
specificity were reported by some studies indicating potential use as a rule-in or 
rule-out strategy. ConClusions: FeNO has variable diagnostic accuracy even 
within subgroups of studies with similar characteristics. However, FeNO could 
be informative within a diagnostic pathway involving other tests. Cut-off values 
should probably be lower in children.
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objeCtives: The Medical Devices Committee (MDC) of the Maggiore Policlinico 
Hospital in Milan, Italy, approved the use of a minimally invasive insertable cardiac 
monitor (ICM). ICMs are leadless subcutaneous devices that continuously moni-
tor the heart rhythm and record events, allowing for the diagnosis of infrequent 
rhythm abnormalities that can be the cause of palpitations, syncope and stroke. 
Given the limited available literature and foreseen increase in expenditure, the 
MDC established an outcome monitoring process in order to test the effectiveness 
of the device in real practice in detecting abnormal heart rhythms and therefore 
diagnose and implement a timely appropriate treatment. Methods: According 
to the literature, available guidelines and clinical opinion, four groups of patients 
would potentially benefit from the ICM insertion: patients with syncope of unknown 
etiology, myocardial infarction (e.g., arrhythmia risk stratification after the event), 
relapsing arrhythmia after transcatheter ablation of atrial fibrillation (AF) and cryp-
togenic stroke. A standardized data collection form was developed for requesting 
the device to the hospital pharmacy, including patient’s characteristics and clinical 
condition for use. A follow up report describing clinical outcomes (e.g. detected 
arrhythmias, time to event, diagnostic formulation) needs to be provided every 6 
months. Results: From 7/2014 to 5/2015, the ICM was implanted in 14 patients. 
The average patients’ age at the time of insertion was 54,8 years (range: 27-84 years). 
78,6% of patients-(11) showed syncope of unknown etiology, 14,2%(2) suffered a 
cryptogenic stroke, while 1 patient-(7,1%) received transcatheter ablation of AF with 
possible anticoagulant antiarrhythmic therapy suspension. A final diagnosis was 
reached for 5(36%) patients; in particular, for 2 a sustained arrhythmia was detected 
within 15 days since the implant. ConClusions: The inclusion in clinical practice 
of a new technology has increased the expenditure for medical devices. However, the 
forthcoming availability of clinical outcomes will document whether the diagnosis 
process has been improved.
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objeCtives: To determine the published frequency of diagnostic discordance 
leading to potential mismanagement of patient treatment for lymphoma by meta-
analysis. Methods: A systematic literature search using PubMed database was 
conducted from 2000 to May 2015. Literature was restricted to articles published 
after 2000, the year the World Health Organization classification of hematologic 
malignancies was published. The search string used was: ((((((patholog*) OR diag-
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objeCtives: Fentanyl iontophoretic transdermal system (ITS) is the first needle-
free, pre-programmed transdermal delivery system for patient-controlled analge-
sia (PCA) and management of acute post-operative pain (POP) in adult patients. 
Clinical practice requires comparisons to POP treatments in current practice such 
as epidurals, multimodal regimens (nerve blocks and intravenous opioids), long act-
ing analgesics, or intravenous PCA. This analysis compared the clinical safety and 
tolerability of fentanyl ITS relative to current POP strategies used following major 
hip and knee orthopedic surgeries. Methods: A systematic literature review was 
conducted to identify all RCTs of fentanyl ITS and POP treatments after major hip 
and knee orthopedic surgeries. Searches in EMBASE, MEDLINE, and the Cochrane 
Central Register of Controlled Trials from 1990 to August 2014 were conducted; 
reference lists of included studies and unpublished study reports were searched. 
The odds-ratios for three safety outcomes, “discontinuation due to adverse events 
[AEs]”, “pruritus” and “respiratory depression” were estimated using fixed- and 
random-effects Bayesian Network Meta-Analysis (NMA) models. Results: Forty 
six RCTs were included in the NMA. The fixed-effects model for “discontinuation 
due to AEs” showed that fentanyl ITS is significantly better than IV PCA morphine 
(OR 0.35, 95% CrI 0.16, 0.70). In the fixed-effects model for “pruritus”, fentanyl ITS 
performed significantly better than IV PCA morphine (OR 0.42, 95% CrI 0.22, 0.78) 
and continuous epidural (OR 0.24, 95% CrI 0.06, 0.93). In the analysis for “respiratory 
depression”, fentanyl ITS was not statistically significantly different from all other 
POP treatments. ConClusions: Fentanyl ITS was comparable with other current 
POP treatments employed to manage POP following major hip and knee surgery, 
offering a similar clinical safety and tolerability profile to current POP alternatives. 
Fentanyl ITS may be a suitable complement for multimodal therapeutic approaches 
or a potential replacement for certain regimens in terms of safety and tolerability.
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objeCtives: Five recently published RCTs showed positive effects of mechanical 
thrombectomy for treating acute ischemic stroke patients. The objective of this 
study is to review the effect of methodological differences in these trials on their 
comparability and results. Methods: This study critically examines the main char-
acteristics of the five RCTs including trial design, inclusion criteria, intervention 
methods and related time factors on the assessment of mechanical thrombec-
tomy trial results. Results: The multicenter trials MR CLEAN, ESCAPE, EXTEND-IA, 
SWIFT-PRIME and REVASCAT prospectively randomised patients to standard care 
(usually thrombolysis) alone or standard care plus mechanical thrombectomy. MR 
CLEAN was notably the only ‘pragmatic trial’. The number of patients randomised 
ranged from 70 to 500, with three studies stopping early due to efficacy. Two RCTs 
used intraarterial treatment where choice of therapy was left to a certain level 
of interventionists’ discretion, with retrievable stents recommended. Three RCTs 
focused on thrombectomy with a specific device, the Solitaire FR stent retriever. 
Inclusion criteria differed in terms of imaging modalities used, thrombus location, 
and time intervals for treatment ranging between 4.5-12 hours after symptom onset. 
Further variations concerned process times and measurement. In all studies, the 
outcome of modified Rankin Scale at 90 days favoured thrombectomy (adjusted odds 
ratios ranged from 1.67 to 3.1). Higher rates of functional independence in favour of 
thrombectomy were noted in all RCTs, improvements ranged from 32.6 vs 19% to 71 
vs 40%. MR CLEAN exclusively reported the safety variable “new ischemic stroke in 
a different vascular territory within 90 days” as 5.6 and 0.4% in the thrombectomy 
and control groups, respectively. ConClusions: The results of five recent RCTs 
focusing on thrombectomy are highly promising but methodological heterogeneity 
of these studies affects the comparability of efficacy and safety results. Caution is 
therefore needed when drawing overall conclusions for HTA reporting.
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objeCtives: Strokes are associated with high rates of morbidity and are the global 
second leading cause of death. Up to 40% of ischaemic strokes are cryptogenic. 
A network meta-analysis to compare the effectiveness of patent foramen ovale 
closure in patients with cryptogenic stroke or embolism. Methods: A systematic 
literature search for randomized clinical trials for patent foramen ovale closure was 
undertaken for the databases Pubmed, Embase, Biosis, Google Scholar and Cochrane. 
Data was collected for the study type, methods, country and key findings. Extracted 
study data included study design, patient charatcertristcis and stroke related out-
comes. A bayesian random effects network meta-analysis model was developed 
objeCtives: The aim of our study was to analyze the clinical pathway of the 
patients with breast tumor, who were screened by the mammographic breast 
screening program. Methods: The data derive from the database of the National 
Health Insurance Fund Administration. The patients include all the women having 
“42400 mammography screening “code in the year of 2008. We followed these 
patients’ first appearances in the health care system. Diagnostic delay was called 
as the time difference between the date of the screening and the date of the 
first appearance in the outpatient care system, the treatment delay called as the 
time difference between the date of screening and the date of first appearance 
in the inpatient care system. Results: In 2008, 232.321 women participated in 
the organized mammography breast screening program in 44 institutions. The 
median value of the diagnostic delay was 47 days. Within diagnostic delay, there 
was a 30 days delay of definitive pathological diagnosis. Based upon the DRG 
codes the median value of the treatment delay was 70.75 days for surgical inter-
ventions and 191.75 days for radiotherapy. In comparison with the 2002 year data 
we found that the diagnostic delay was usually decreased with 10-20 days, while 
the median value of the treatment delays was increased on the average of 26-30 
days. In 2012 the same delays were about twice longer. ConClusions: In com-
parison with the dates described by the international literature our national health 
care system works 1.5-2 times longer delays. The examination of the patients’ 
clinical pathways may allow of determining diagnostic and treatment delays of 
health care system. It would be necessary to optimize and reduce the clinical 
pathways with the participation of the all the professionals involving oncologic 
patients’ clinical pathway, and to determine the expected and achieved standard 
values.
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objeCtives: In the differential diagnosis of a simple contact dermatitis (CD) and 
pressure ulcers (PU) in patients with urinary and fixed holds a special place visual 
assessment of skin. However, not all possess this skill, and telemedicine consulta-
tions are considered expensive. Methods: The researcher evaluated the patient’s 
skin by questionnaire, and then spent photographic images of the skin in the 
standard points. Expert remotely evaluated the skin by photographs and then the 
diagnoses were compared. Calculated the cost of the methodology. Results: The 
expert noted no changes of the skin in 459 (86.3%) points at the bedside only 383 
(72%) points. According to the expert diagnosis was made in 29 (5.5%) points, 1-2 
tbsp. PU is set to 39 (7.3%) points 3-4 art. P - 5 (0.9%) points. Immediately patient 
diagnosed CD 53 set (10%) points 1-2 tbsp. PU - 88 (16.5%) points 3-4 tablespoons. 
PU - 8 (1.5%) points. Expert significantly less often seen in photographs erythema, 
cracks and peeling. According to the results of teleconsultation diagnosis pressure 
ulcers raised 2 times less frequently than directly from the patient. Almost 2 times 
less expert described contact dermatitis. The number of mismatches conclusions 
severe pressure ulcers with other changes of the skin is relatively low and difficult 
to interpret. The total costs of teleconsultation was 5 $ for 1 patient. ConClusions: 
The use of teleconsultation allows for a relatively low cost to refine the differential 
diagnosis of CD and PU, which optimizes tactics of conducting patients, reduces 
the overall cost of patients.
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objeCtives: Accurate estimation of blood loss is central to prompt diagnosis and 
management of post-partum hemorrhage(PPH), which remains a leading cause of 
maternal mortality in low-resource countries. In such settings, blood loss is often 
estimated visually and subjectively by attending health workers, due to inconsist-
ent availability of laboratory infrastructure. We evaluated the diagnostic accuracy 
of weighed blood loss(WBL) versus changes in peri-partum hemoglobin to detect 
PPH. Methods: Data from this analysis were collected as part of a randomized 
controlled trial comparing oxytocin with misoprostol for PPH(NCT01866241). Two 
blood samples for complete blood count were drawn on admission and prior to 
hospital discharge or before blood transfusion. After delivery, blood was drained 
into a calibrated measuring jar and the subsequent weight differences of pre-
weighed sanitary towels added to estimate WBL(1g= 1mL).Sensitivity, specificity, 
negative and positive predictive values(PPVs) were calculated and receiver-oper-
ator curves fitted. Results: A total of 1,140 women were enrolled in the study, of 
whom 258(22.6%) developed PPH, defined as a hemoglobin drop > 10%, and 23.0% 
had WBL ≥ 500mL.WBL generally had a poor sensitivity for detection of PPH(< 75% 
for most volume-time combinations). In contrast, the specificity of the WBL was 
high with blood loss ≥ 500mL at 1h and ≥ 750mL at all-time points excluding PPH 
in over 97% of women. As such, WBL has promise as a diagnostic technique to 
identify PPH in higher-prevalence settings, where the high specificity corresponds 
to a high PPV(> 85%) when WBL exceeds 750mL. ConClusions: WBL has poor 
sensitivity but high specificity for PPH versus laboratory-based methods of hem-
orrhage detection. These characteristics correspond to a high PPV in areas with 
high PPH prevalence. Although WBL is not useful for excluding PPH, this low-cost, 
simple and reproducible method seems promising as a reasonable alternative 
method to “rule-in” significant PPH in such settings where quantifiable red cell 
indices are unavailable.
